# Controlled Study to Evaluate the Efficacy and Safety of Racecadotril in Infants, Children and Adolescents With Acute Diarrhea

> **NCT03463512** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 124 (actual)

## Conditions studied

- Diarrhea

## Interventions

- **DRUG:** Racecadotril plus ORS
- **DRUG:** ORS

## Key facts

- **NCT ID:** NCT03463512
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-29
- **Primary completion:** 2018-09-10
- **Final completion:** 2018-09-10
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2019-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03463512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03463512, "Controlled Study to Evaluate the Efficacy and Safety of Racecadotril in Infants, Children and Adolescents With Acute Diarrhea". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03463512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*